- United Kingdom
Clive Bates has had a diverse career in the public, private and not-for-profit sectors. Starting out with IBM, he then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Tony Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of The Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.
Dr Roberto A Sussman (PhD University of London) is a full time senior researcher and lecturer at the Institute for Nuclear Sciences of the National University of Mexico. His main research areas are General Relativity and Cosmology, but he has conducted research in other areas of Physics, including peer reviewed publications on e-cigarette aerosols. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the gubernmental misinformation and prejudice about them that is rampant throughout Latin America.
- New Zealand
Marewa Glover is director of the independent Centre of Research Excellence: Indigenous Sovereignty & Smoking based in Auckland, New Zealand. Funded by the Foundation for a Smoke-Free World, the center aims to reduce the harms associated with tobacco use among all indigenous people globally. Glover is also tobacco section editor for the international Harm Reduction Journal.
As a behavioral scientist, Glover has led and collaborated on many studies resulting in more than 100 scientific publications. In 2019, she was one of three finalists for the prestigious New Zealander of the Year Award in recognition of her dedication to reducing tobacco smoking harm over the past 30 years and advocating for a harm-reduction approach to combustible cigarette smoking.
In June 2019, Glover won awards for Best Picture and Best Director at the Global Forum on Nicotine in Warsaw, Poland, for a short video series that she wrote and commissioned. At the 2018 Global Forum on Nicotine Glover received the Outstanding Advocate award from the International Network of Nicotine Consumer Organizations. Glover is a former professor of public health at Massey University and a former chair of End Smoking NZ, a charitable trust that has lobbied for tobacco harm reduction for more than a decade.
Dr. Moira Gilchrist leads the global strategic and scientific communications for Philip Morris International (PMI). From bringing to life PMI’s fast-pace progress as it evolves into a smoke-free business and expands in areas outside the tobacco and nicotine space, to translating the science behind PMI’s smoke-free alternatives into information that policymakers and the public can easily understand, Moira and her team are at the heart of the company’s historic evolution. She regularly engages with public health authorities, media, and decision-makers around the world, demonstrating the benefits of scientifically substantiated, smoke-free products for those adults who would otherwise continue smoking and calling for risk-proportionate regulation that affords these people accurate information about and access to these better alternatives. In short, she plays a vital role in PMI’s transition away from cigarettes and its journey toward a better, smoke-free future.
Prior to her current role, Moira held several positions within PMI, including leading the
Reduced-Risk Products Corporate Affairs team, serving as director of Scientific
Engagement within the R&D function, and working in both product development and
Before joining PMI in 2006, Moira worked in the pharmaceutical sector for more than a
decade. She was a principal consultant within PwC’s and IBM’s pharmaceutical industry
consulting groups and held positions within both industry and nonprofit organizations as
a developer of drug formulations.
Moira holds a degree in Pharmacy and a PhD in Pharmaceutical Sciences, both from the
University of Strathclyde in Glasgow, Scotland.